How statins could be more effective in treatment of ovarian cancer

July 14, 2017, Keele University

A new study led by Keele University has shown how statins may be used as a potentially effective treatment against ovarian cancer.

Previous laboratory studies have largely been positive and shown statins to be active against cells but, in contrast, when statins have been tested in real human patients with cancer, they have largely been ineffective. Published this week in Scientific Reports, the new research provides an explanation for this paradox and recommends the improved design for a new clinical trial.

Dr Alan Richardson, who led the research at Keele and co-authored the paper, explained:

"We believe we have found the answer to the paradox: for statins to be effective as a cancer therapy, the right statin needs to be used, it needs to be delivered at the right dose and interval, and diet needs to be controlled to reduce sources of geranylgeraniol, which can limit the statin's effect on cancer cells."

The researchers at Keele University identified that a particular called pitavastatin is uniquely suited to target cells because it combines a suitably long metabolic half-life (allowing it to continually inhibit tumour growth) with a structure which makes it a potent inhibitor of in mice. However, it was also found that diet can limit the effectiveness of pitavastatin. Retrospective clinical studies of human patients taking statins to reduce cholesterol have also shown some reduced risk of dying of cancer.

Dr Richardson, whose work focuses on ovarian cancer, is the Therapeutics theme lead in the Institute of Science and Technology in Medicine and a Reader in Pharmacology in the School of Pharmacy at Keele University. He is also the author of the "Why do scientists do what scientists do?" website (whydoscientists.org/) which provides a lay explanation of how scientists design and interpret experiments. He explained:

"Our research found that the tumour-inhibiting effects of pitavastatin in mice were limited when dietary geranylgeraniol was present. Statins work in cancer by preventing making geranylgeraniol. However, geranylgeraniol is present in various foods including sunflower oil and some rice, so in future clinical , we need to carefully control diet to limit geranylgeraniol."

The next stage of research will be to conduct full clinical trials in humans - something that Dr Richardson and his team are already planning.

Dr Richardson commented:

"The key message of our work is that of pitavastatin can now be properly designed, and we are in the very early stages of developing trials with our colleagues at Keele University and Birmingham University. It is also noteworthy that pitavastatin is available in a generic form, potentially making this a relatively inexpensive treatment."

Explore further: Statins do not benefit patients with lung cancer, new study shows

Related Stories

Statins do not benefit patients with lung cancer, new study shows

February 27, 2017
Cholesterol-lowering drugs used alongside chemotherapy have no effect on treatment outcomes for lung cancer patients, according to a new study.

Researchers find alternative cholesterol-lowering drug for patients who can't tolerate statins

March 11, 2013
Heart patients who can't tolerate the side effects of cholesterol-lowering drugs may have a new option, according to a new study by researchers from the Intermountain Heart Institute at Intermountain Medical Center in Salt ...

Study finds no link between statins and cancer risk

July 25, 2011
(Medical Xpress) -- A new study published in the Journal of the American College of Cardiology reports that, contrary to previous studies, the use of cholesterol reducing statin drugs does not increase the risk of patients ...

Statin use associated with reduced risk of prostate cancer recurrence

May 2, 2014
(Medical Xpress)—Men who begin taking statins after prostate cancer surgery are less likely to have a recurrence of their cancer, according to a retrospective analysis led by researchers at Duke Medicine.

Amino acids in diet could be key to starving cancer

April 19, 2017
Cutting out certain amino acids—the building blocks of proteins—from the diet of mice slows tumour growth and prolongs survival, according to new research published in Nature.

Study suggests link between cholesterol drugs and lower risk of cancer death

June 5, 2015
Women who take statins – drugs that lower cholesterol levels – seem to have a lower risk of dying from cancer, according to results of a large study presented at a US conference.

Recommended for you

Scientists identify 170 potential lung cancer drug targets using unique cellular library

April 19, 2018
After testing more than 200,000 chemical compounds, UT Southwestern's Simmons Cancer Center researchers have identified 170 chemicals that are potential candidates for development into drug therapies for lung cancer.

Discovery adds to evidence that some children are predisposed to develop leukemia

April 19, 2018
St. Jude Children's Research Hospital researchers have made a discovery that expands the list of genes to include when screening individuals for possible increased susceptibility to childhood leukemia. The finding is reported ...

Mechanism that drives development of liver cancer brought on by non-alcoholic fatty liver disease discovered

April 19, 2018
A team of researchers from several institutions in China has found a mechanism that appears to drive the development of a type of liver cancer not caused by alcohol consumption. In their paper published in the journal Science ...

Protein can slow intestinal tumor growth

April 19, 2018
A new mechanism for regulating stem cells in the intestine of fruit flies has been discovered by researchers at Stockholm University. In addition, it was discovered that a certain protein can slow the growth of tumours in ...

Chip-based blood test for multiple myeloma could make bone biopsies a relic of the past

April 19, 2018
The diagnosis and treatment of multiple myeloma, a cancer affecting plasma cells, traditionally forces patients to suffer through a painful bone biopsy. During that procedure, doctors insert a bone-biopsy needle through an ...

Study may explain why some triple-negative breast cancers are resistant to chemotherapy

April 19, 2018
Triple-negative breast cancer (TNBC) is an aggressive form of the disease accounting for 12 to 18 percent of breast cancers. It is a scary diagnosis, and even though chemotherapy can be effective as standard-of-care, many ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.